Pharmafile Logo

Video: Patient level prescribing decisions

February 9, 2016 | market research, patients 

Quantitative Director Duncan Munro explores the benefits of using patient level prescribing decisions.

There is no “one size fits all” approach to conducting demand assessments. The best studies utilise a methodology which is appropriate to the product in development, the market in which it will launch, and which gives the respondent the most realistic experience.  In this video, Duncan discusses the importance of using patient level prescribing data to better reflect doctor’s real world choices.

Watch the video:
www.researchpartnership.com/news/2016/01/video-patient-level-prescribing-decisions/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Quantitative specialist joins Research Partnership, London

Global healthcare market research consultancy Research Partnership has appointed Roy Rogers as a Quantitative Director in their UK offices in London

Webcast

Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights

Webcast

The power of a good story: Turn your insights into effective storytelling with data visualisation

Article

How will COVID-19 affect uptake of vaccinations against other diseases?

Podcast

Living With Chronic Illness (Series one)

Webcast

China: How pharma can maximize success in this rapidly changing emerging market

Article

Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma

Infographic

Migraine market snapshot

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19